Jefferies Financial Group's Rating of City Therapeutics on 11/16/2026

On November 16, 2026, Jefferies Financial Group updated its outlook on City Therapeutics (NASDAQ:CTY) with the action "Initiated Coverage", setting a "Strong-Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Jefferies Financial Group Inc.

DateCompanyAction
11/17/2026
LYCA
Lycia Therapeutics
Initiated Coverage
11/17/2026
IDACORP, Inc. stock logo
IDA
IDACORP
Downgrade
11/17/2026
Great Portland Estates Plc stock logo
GPE
Great Portland Estates
Reiterated Rating
11/17/2026
Big Yellow Group Plc stock logo
BYG
Big Yellow Group
Boost Price Target
11/17/2026
Ceres Power Holdings plc stock logo
CWR
Ceres Power
Reiterated Rating
11/17/2026
Sirius Real Estate Limited stock logo
SRE
Sirius Real Estate
Boost Price Target
More Ratings From Jefferies Financial Group Inc.